Work

Clinical utility of antifungal susceptibility testing

Year: 2022

Type: article

Abstract: Invasive fungal diseases cause significant morbidity and mortality, in particular affecting immunocompromised patients. Resistant organisms are of increasing importance, yet there are many notable differences in the ability to both perform and interpret antifungal susceptibility testing compared with bacteria. In this review, we will highlight the strengths and limitations of resistance data of pathogenic yeasts and moulds that may be used to guide treatment and predict clinical outcomes.

Source: JAC-Antimicrobial Resistance

DOI: 10.1093/jacamr/dlac067

Authors: Todd P McCarty, Paul M Luethy, John W Baddley, Peter G Pappas

Institutions: University of Alabama at Birmingham, Birmingham VA Medical Center, University of Maryland, Baltimore

Language: English

Topic: Antifungal resistance and susceptibility

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,219